Skip to content
777 Sourcing.

Capability

small molecule therapeutic development

Suppliers
2
States & provinces
2
Countries
1

2 small molecule therapeutic development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AERYS BIOSCIENCES, INC.

PALO ALTO, CA

Aerys Biosciences is a clinical-stage biopharmaceutical company headquartered in Stanford Research Park, Palo Alto, California, spun out of Stanford University and Greenstone Biosciences. It develops next-generation small-molecule therapies for fibro-inflammatory lung diseases, including idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), targeting mechanisms driving fibrosis and vascular remodeling.

drug repurposingearly-stage clinical trialshIPSC-based disease modelshuman-relevant drug discoverypreclinical and translational studies

Compiled from public sources

KULEON LLC

SEATTLE, WA

Küleon is a drug discovery and development company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases and disorders. It develops small molecule therapeutics for neuropsychiatric conditions modulated through serotonin receptors in the prefrontal cortex of the brain, targeting conditions including addiction, schizophrenia, obesity, pain, inflammation, and neurodegeneration.

AI-based drug discovery technology

Compiled from public sources

Related capabilities

Other processes offered by the shops that list small molecule therapeutic development.

Browse all capabilities